Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hyperthermia × Folfox protocol × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 54 Rectal Neoplasms 25 Colonic Neoplasms 24 Carcinoma, Hepatocellular 21 Neoplasm Metastasis 15 Stomach Neoplasms 10 Pancreatic Neoplasms 6 Cholangiocarcinoma 6 Adenocarcinoma Of Esophagus 5 Recurrence 4 Esophageal Neoplasms 4 Biliary Tract Neoplasms 4 Neoplasms 3 Liver Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Neoplastic Cells, Circulating 2 Gastrointestinal Neoplasms 2 Cirrhosis, Familial, with Pulmonary Hypertension 2 Adenocarcinoma 2 Postoperative Complications 1 Peripheral Nervous System Diseases 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma 1 Operable T2-3N+M0 Rectal Cancer (Stage III) 1 Oligometastatic Gastric Adenocarcinoma 1 Neurotoxicity Syndromes 1 Neuropathy, Painful 1 Neuralgia 1 Neoplasms, Second Primary 1 Neoplasm, Residual 1

Interventions

Diathermy 15 Radiotherapy 9 Drug Therapy 4 Immune Checkpoint Inhibitors 3 Fluorouracil 3 Cisplatin 3 tislelizumab 2 Surgical Procedures, Operative 2 Radiation 2 Immunotherapy 2 Conization 2 Brachytherapy 2 spartalizumab 1 anlotinib 1 Solutions 1 Patient Reported Outcome Measures 1 Paclitaxel 1 Mitomycin 1 Ifosfamide 1 Hyperthermic Intraperitoneal Chemotherapy 1 Hyperthermia, Induced 1 Hydrogen Peroxide 1 Gemcitabine 1 Folfox protocol 1 Doxorubicin 1 Docetaxel 1 Dacarbazine 1 Cytoreduction Surgical Procedures 1 Cyclophosphamide 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06831981 2025-02-18

ARO 2024-13

University Hospital Tuebingen

Phase NA Recruiting

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡